We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$16.2B
AUM Growth
+$1.63B
Cap. Flow
+$893M
Cap. Flow %
5.51%
Top 10 Hldgs %
15.16%
Holding
2,286
New
215
Increased
1,251
Reduced
646
Closed
120

Sector Composition

Rank Sector Weight
1 Energy 9.92%
2 Technology 7.94%
3 Healthcare 7.8%
4 Financials 7.55%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWLT
1951
DELISTED
FOSTER WHEELER AG (SWITZERLAND)
FWLT
$374K ﹤0.01%
10,990
-1,446
-12% -$48.9K
HLT icon
1952
Hilton Worldwide
HLT
$72.5B
$372K ﹤0.01%
5,316
-4,890
-48% -$325K
SRV
1953
NXG Cushing Midstream Energy Fund
SRV
$216M
$371K ﹤0.01%
2,102
-522
-20% -$89.3K
ABMD
1954
DELISTED
Abiomed Inc
ABMD
$370K ﹤0.01%
+14,700
New +$342K
IPO icon
1955
Renaissance IPO ETF
IPO
$157M
$369K ﹤0.01%
16,125
-73
-0.5% -$1.58K
STK
1956
Columbia Seligman Premium Technology Growth Fund
STK
$910M
$364K ﹤0.01%
21,488
+2,607
+14% +$42.8K
BCS.PRD.CL
1957
DELISTED
Barclays Bank Plc
BCS.PRD.CL
$364K ﹤0.01%
14,068
-479
-3% -$12.4K
NBR icon
1958
Nabors Industries
NBR
$1.23B
$361K ﹤0.01%
246
-441
-64% -$570K
ICB
1959
DELISTED
Morgan Stanley Income Sec. Inc
ICB
$361K ﹤0.01%
19,978
+5
+0% +$89
PSF icon
1960
Cohen & Steers Select Preferred & Income Fund
PSF
$235M
$360K ﹤0.01%
13,612
-3,234
-19% -$82.9K
HIO
1961
Western Asset High Income Opportunity Fund
HIO
$337M
$359K ﹤0.01%
58,913
-15
-0% -$91
HTH icon
1962
Hilltop Holdings
HTH
$2.25B
$359K ﹤0.01%
16,880
-2,273
-12% -$49.8K
NASB
1963
DELISTED
NASB FINL INC
NASB
$358K ﹤0.01%
15,122
AVTA
1964
DELISTED
Avantax, Inc. Common Stock
AVTA
$357K ﹤0.01%
+18,935
New +$357K
HOLI
1965
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$356K ﹤0.01%
14,521
-2,502
-15% -$54.4K
EOX
1966
DELISTED
EMERALD OIL INC (MT)
EOX
$354K ﹤0.01%
+2,315
New +$315K
GSIT icon
1967
GSI Technology
GSIT
$254M
$351K ﹤0.01%
58,953
-30,007
-34% -$180K
DKL icon
1968
Delek Logistics
DKL
$3.13B
$350K ﹤0.01%
+10,160
New +$344K
UUU icon
1969
Universal Safety Products Inc
UUU
$10.8M
$350K ﹤0.01%
76,939
-3,000
-4% -$13.2K
RAVN
1970
DELISTED
Raven Industries Inc
RAVN
$348K ﹤0.01%
+10,500
New +$335K
XCO
1971
DELISTED
Exco Resources
XCO
$348K ﹤0.01%
3,944
+1,415
+56% +$120K
ENBL
1972
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$347K ﹤0.01%
+13,250
New +$321K
CSIQ icon
1973
Canadian Solar
CSIQ
$1.05B
$346K ﹤0.01%
+11,075
New +$299K
GILD icon
1974
CALL
Gilead Sciences
GILD
$162B
$346K ﹤0.01%
+144,000
New +$11.2M
NVRI icon
1975
Enviri
NVRI
$630M
$344K ﹤0.01%
12,925
+751
+6% +$19.2K

Similar funds

Raymond James & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Raymond James & Associates held 2,286 positions worth $16.2B, up 11% from $14.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $893M of net new capital in Q2 2014, opening 215 new positions and adding to 1,251 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.

By sector, the portfolio is most concentrated in Energy at 9.9% of assets, up from 9.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was AstraZeneca, an estimated $38.6M trimmed.

  • Raymond James & Associates's largest Q2 2014 buy was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.
  • Raymond James & Associates added most to iShares MSCI EAFE ETF in Q2 2014, an estimated $38.2M increase.
  • Raymond James & Associates's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $38.6M.
  • Raymond James & Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $20.6M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $16.2B portfolio in Q2 2014.
  • Raymond James & Associates opened 215 new positions and closed 120 in Q2 2014.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $16.2B.

Based on Raymond James & Associates's 13F filing for Q2 2014, filed 13 Aug 2014.